AMRX - Amneal Pharmaceuticals' (AMRX) CEO Rob Stewart on Q1 2019 Results - Earnings Call Transcript
Amneal Pharmaceuticals, Inc. (AMRX)
Q1 2019 Earnings Conference Call
May 09, 2019 8:30 AM ET
Company Participants
Mark Donohue – Vice President of Investor Relations and Corporate Communications
Rob Stewart – President and Chief Executive Officer
Todd Branning – Chief Financial Officer
Joe Todisco – Senior Vice President of Specialty Commercial
Conference Call Participants
Jennifer Kim – Cantor Fitzgerald
Gary Nachman – BMO Capital Markets
David Amsellem – Piper Jaffray
Eason Lee – SVB Leerink
Greg Fraser – SunTrust
Dewey Steadman – Canaccord
Dan Busby – RBC Capital
Tim Chiang – BTIG
Presentation
Operator
Good